Balyasny Asset Management

Balyasny Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Balyasny Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell
2020 Q4	$87K	Buy
2020 Q2	–	Sell
2020 Q1	$1.07M	Buy
2018 Q3	–	Sell
2018 Q2	$161K	Buy
2018 Q1	$176K	Buy
2017 Q3	–	Sell
2017 Q2	$8.44M	Sell
2017 Q1	$7.68M	Buy
2016 Q4	$3.85M	Buy